Veterinary Medicines

Bovilis Nasalgen-C (--) - Nasal spray, lyophilisate and solvent for suspension

Authorised
  • Bovine coronavirus, strain CA25, Live
Download as PDF

Product identification

Medicine name:
Bovilis Nasalgen-C (--) - Nasal spray, lyophilisate and solvent for suspension
Active substance:
  • Bovine coronavirus, strain CA25, Live
Target species:
  • Cattle
Route of administration:
  • Nasal use

Product details

Active substance and strength:
  • Bovine coronavirus, strain CA25, Live
    Presentation_strength:≥ 5.4 log₁₀ TCID₅₀ ≤ 7.8 log₁₀ TCID₅₀ Reference:Hse Index:0
Pharmaceutical form:
  • Nasal spray, lyophilisate and solvent for suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AD10
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Available in:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • France
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Package description:
  • Packaging:Lyophlisate: vial (glass); solvent: vial (glass), Package_size:Lyophilisate: 1 vial + solvent: 1 vial, Content:Lyophilisate: 50 doses + solvent: 100 ml
  • Packaging:Lyophlisate: vial (glass); solvent: vial (glass), Package_size:Lyophilisate: 1 vial+ solvent: 1 vial, Content:Lyophilisate: 20 doses + solvent: 40 ml
  • Packaging:Lyophlisate: vial (glass); solvent: vial (glass), Package_size:Lyophilisate: 5 vials + solvent: 5 vials, Content:Lyophilisate: 5 x 10 doses + solvent: 5 x 20 ml
  • Packaging:Lyophlisate: vial (glass); solvent: vial (glass), Package_size:Lyophilisate: 5 vials + solvent: 5 vials, Content:Lyophilisate: 5 x 5 doses + solvent: 5 x 10 ml
  • Packaging:Lyophlisate: vial (glass); solvent: vial (glass), Package_size:Lyophilisate: 5 vials + solvent: 5 vials, Content:Lyophilisate: 5 doses; solvent: 10 ml
  • Packaging:Lyophlisate: vial (glass); solvent: vial (glass), Package_size:Lyophilisate: 1 vial + solvent: 1 vial, Content:Lyophlilsate: 10 doses + solvent: 20 ml
  • Packaging:Lyophlisate: vial (glass); solvent: vial (glass), Package_size:Lyophilisate: 1 vials + solvent: 1 vial, Content:Lyophilisate: 5 doses + solvent: 10 ml
  • Packaging:Lyophlisate: vial (glass); solvent: vial (glass), Package_size:Lyophilisate: 1 vial + solvent: 1 vial, Content:Lyophlisate: 1 dose; solvent: 2 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 17/12/2024
Download
Bulgarian (PDF)
Published on: 17/12/2024
Download
Croatian (PDF)
Published on: 17/12/2024
Download
Czech (PDF)
Published on: 17/12/2024
Download
Danish (PDF)
Published on: 17/12/2024
Download
Dutch (PDF)
Published on: 17/12/2024
Download
Estonian (PDF)
Published on: 17/12/2024
Download
Finnish (PDF)
Published on: 17/12/2024
Download
French (PDF)
Published on: 17/12/2024
Download
German (PDF)
Published on: 17/12/2024
Download
Greek (PDF)
Published on: 17/12/2024
Download
Hungarian (PDF)
Published on: 17/12/2024
Download
Icelandic (PDF)
Published on: 17/12/2024
Download
Italian (PDF)
Published on: 17/12/2024
Download
Latvian (PDF)
Published on: 17/12/2024
Download
Lithuanian (PDF)
Published on: 17/12/2024
Download
Maltese (PDF)
Published on: 17/12/2024
Download
Norwegian (PDF)
Published on: 17/12/2024
Download
Polish (PDF)
Published on: 17/12/2024
Download
Portuguese (PDF)
Published on: 17/12/2024
Download
Romanian (PDF)
Published on: 17/12/2024
Download
Slovak (PDF)
Published on: 17/12/2024
Download
Slovenian (PDF)
Published on: 17/12/2024
Download
Spanish (PDF)
Published on: 17/12/2024
Download
Swedish (PDF)
Published on: 17/12/2024
Download

ema-puar-v5906-bovilis-nasalgen-c-en.pdf

English (PDF)
Published on: 21/02/2024
Download